A Brand New Professional Network
to Crack Solid Tumors
Shining a bright light on the search for solid tumor solutions
through collaborative scientific exchange
A private network for CAR-TCR drug developers
designed by CAR-TCR drug developers
Solid tumors account for 90% of cancer incidences worldwide, presenting a significant unmet need. While progress is being made, siloed innovation has not been enough to deliver significant clinical outcomes in solid tumors.
The CAR-TCR Solid Tumor: Searchlight network is designed to address critical R&D challenges in CAR-TCR therapies for solid tumors. By facilitating the exchange of experiences and learnings across a diverse range of novel approaches, including CAR-T, TCR, NK, TIL, and macrophage cell therapies, we aim to overcome key shared challenges as a collective.
Through regular engagement, network members better understand and interpret new data as it emerges to better inform decision making and best practices for our individual solid tumor programs.
Join our global network of CAR-T leaders today and become part of a powerful community that is shaping the future of CAR-TCR development for solid tumors!
Business critical conversations
Virtual cornerstone meetings
We facilitate, structured, discussion-driven, CAR-TCR-focused quarterly meetings for member companies.
Each high-impact 90-minute meeting takes place virtually via Zoom. The meeting agenda is carefully curated and focused on the topics and critical challenges requested by Searchlight members.
Member companies are represented by one internal champion with strategic oversight over its CAR-TCR program to ensure that each discussion is high-value, high-impact, and delivers tangible outputs for members to take back to their organization.
A focus on solving shared challenges
The topic ranked pre-competitive challenges chosen by the networks founding partners to tackle this year:
Network with the best in the field
Gain insider knowledge and insights from scientific advisors
Professor of Medicine
Keck School of Medicine of USC
Vice President & Director - Protein Sciences & Biologics
Innovation doesn’t happen in isolation
Searchlight makes meaningful progress
“It's an opportunity to share experience from the challenges and solutions that I've seen over the my career and also to learn from others to better prepare for what is coming in advanced therapy development.”
“The biggest advantage of collaboration is to advance a field more quickly for the benefit of the patient. This platform will allow everybody share their experience, success and failures and together so we can advance our therapies forward more quickly”
“I believe that to advance a field as a collective, it's vital to exchange experience and learnings with peers. This network can allow us to channel the energy we all share for the science into better understanding of concepts to address solid tumors with cell therapy.”
The Searchlight platform
Build meaningful relationships and gain value all year around
Contact fellow members via the private or group chat features.
Come together with leaders throughout the community at virtual cornerstone meetings and in-person gatherings at Hanson Wade conferences.
Explore the library of business critical content and videos on demand via the thematic rooms and content channels.
For more information on what’s included as part of the CAR-TCR Solid Tumor: Searchlight membership, please download our membership brochure.
Here’s what you’ll learn more about:
- The unique mission and purpose of the network
- What membership includes
- How the quarterly cornerstone meetings work
- How bespoke value delivery works
- How we deliver demonstrable value to you
- Annual member investment